tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Kristen Kluska, 199 are a BUY (91.71%), 18 are a HOLD (8.29%).
Analyst Kristen Kluska, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 32.45% that have a potential upside of 32.95% achieved within 83 days.
Kristen Kluska’s has documented 422 price targets and ratings displayed on 35 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on FULC, Fulcrum Therapeutics at 15-May-2025.
Analyst best performing recommendations are on OCGN (OCUGEN).
The best stock recommendation documented was for OCGN (OCUGEN) at 2/3/2021. The price target of $4 was fulfilled within 2 days with a profit of $1.19 (42.35%) receiving and performance score of 211.74.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$50
$28.65 (134.19%)
$80
30 days ago
(08-May-2025)
6/30 (20%)
$31.67 (172.78%)
256
Buy
$67
$45.65 (213.82%)
$67
4 months 10 days ago
(28-Jan-2025)
4/18 (22.22%)
$41.49 (162.64%)
62
Hold
$37
$15.65 (73.30%)
$35
9 months 27 days ago
(11-Aug-2024)
4/4 (100%)
$3.54 (10.58%)
165
Buy
$90
$68.65 (321.55%)
$72
1 years 3 months 12 days ago
(26-Feb-2024)
0/4 (0%)
$38.96 (76.33%)
Buy
$68
$46.65 (218.50%)
$70
1 years 9 months 28 days ago
(10-Aug-2023)
0/3 (0%)
$37.77 (124.94%)
Which stock is Kristen Kluska is most bullish on?
Which stock is Kristen Kluska is most reserved on?
What Year was the first public recommendation made by Kristen Kluska?
